Repligen Corporation Financials

Market Capitalization $7.16 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	511.11
Forward PE	71.61
Price to Sales TTM	$11.01
Price to Book MRQ	$3.61
Enterprise to Revenue	10.72
Enterprise to EBITDA	61.51

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	-3.53%
Operating Margin	5.59%
Return on Assets TTM	0.92%
Return on Equity TTM	-1.16%

Income Statement

Revenue TTM	$650,428,992
Revenue per Share TTM	$11.61
Quarterly Revenue Growth	10.40%
Gross Profit TTM	$332,694,016
EBITDA	$47,622,000
Net Income to Common TTM	$-22,980,000
Diluted EPS TTM	$-0.42
Quarterly Earnings Growth YoY	76.90%

Balance Sheet

Total Cash MRQ	$697,228,992
Total Cash per Share MRQ	$12.41
Total Debt MRQ	$
Total Debt to Equity MRQ	34.44
Current Ratio MRQ	6.79
Book Value per Share MRQ	$35.34

Cash Flow

Operating Cash Flow TTM	$145,691,008
Levered Free Cash Flow TTM	$183,660,368

RGEN Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	56,091,677
Float Shares	52,572,212
Avg 10 Volume	687,750
Avg 30 Volume	None
Shares Short	3,391,049
Short Ratio	4.73
Short % of Shares	8.14%
% Held by Insiders	6.41%
% Held by Institutions	105.18%

Stock Price Summary

Beta	1.11
Fifty Two Week Low	$102.97
Fifty Two Week High	$182.52
Fifty Two Week Change	5.80%
Day 50 MA	$128.08
Day 200 MA	$141.28

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date